BioSpace News Archive

The companies are facing questions in a criminal probe regarding their marketing distribution practices related to the sale of opioids.

Even with a shortened week due to the U.S. Thanksgiving holiday, there was plenty of clinical trial news and updates. Here’s a look.

There are currently three antivirals approved by the U.S. Food and Drug Administration (FDA) for genital herpes. They are acyclovir (Sitavig and Zovirax), valacyclovir (Valtrex), and famciclovir (Famvir). There are no approved vaccines.

Celebrating success across life sciences

Appropriately selected anticoagulation therapy can help to reduce the medical costs of patients suffering from atrial fibrillation.

Data show that the implantation procedure of the Genio® system is relatively non-invasive

Combination of Prexigebersen and Decitabine Showed Encouraging Safety and Efficacy Results

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, announced that management will participate in the following investor conferences in December

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, announced that it will participate in the Piper Jaffray 31st Annual Healthcare Conference in New York, NY.

First Product Developed from Spatial Transcriptomics Acquisition